Ruchika Sood¹ and Shweta Hinduja²

¹Director at Neocare Orofacial Pain Relief centre, India
²Associate oral physician at Neocare Orofacial Pain Relief centre, India

*Corresponding Author: Shweta Hinduja, Associate oral physician at Neocare Orofacial Pain Relief Centre, India.

Received: February 23, 2023; Published: March 09, 2023

Abstract

OSA is a sleep disorder characterized by obstruction in the oro nasal airflow lasting for more than 10 seconds. The patient experiences being chocked during sleep and thereby transient awakening, which further caused reduced oxygen saturation. This partial cessation of airflow due to obstruction in the upper pharynx or nasal cavity results in snoring, known as ‘hypoaponea’, during each episode of which a reduction is respiratory effort with ≥ 4% oxygen desaturation is recorded. Each episode lasts for 10- 40 seconds, sometimes may last for one minute, during which there maybe abrupt drop in the oxygen saturation level as much as 40% in severe cases. The brain responds to each of these episodes by alerting the body and causing deep arousal from sleep that causes normal breathing, referred to as fragmented sleep quality. OSA is characterized by total number of aponea and hypoaponeas occurring per hour of sleep, which refers to/aponea/hypoaponea index (AHI) [1]. AHI is accounted for in polysomnography test which is an attended setting (sleep Laboratory) test, along with several sleep variables, such as the respiratory disturbance index (RDI). RDI is defined as sum of the aponeas, hyopapneas and abnormal respiratory events per hour of sleep [2].

References

1. Mohanty N and Pattanaik S. “Obstructive sleep aponea-a review”. Journal of Evolution of Medical and Dental Sciences 27 (2008).
2. Medical Advisory Secretariat. “Polysomnography in patients with obstructive sleep apnea: an evidence-based analysis”. Ontario Health Technology Assessment Series 13 (2006): 1-38.
3. Lee W., et al. “Epidemiology of Obstructive Sleep Apnea: A Population-based Perspective”. Expert Review of Respiratory Medicine 3 (2008): 349-364.
4. Schiffman E., et al. “Diagnostic criteria for temporomandibular disorders (Dc/Tmd) for clinical and research applications: Recommendations of the international Rdc/Tmd consortium network* and orofacial pain special interest group dagger”. Journal of Oral Facial Pain Headache 28 (2014): 6-27.
5. Poveda Roda R., et al. “Review of temporomandibular joint pathology. Part i: Classification, epidemiology and risk factors”. Medicina Oral, Patologia Oral y Cirugia Bucal 12 (2007): 292-298”.
6. Liao CH., et al. “The risk of temporomandibular disorder in patients with depression: A population-based cohort study”. Community Dentistry and Oral Epidemiology 39 (2011): 525-531.
7. Oral K., et al. “Etiology of temporomandibular disorder pain”. Agriculture 21 (2009): 89-94.
8. Lin CY., et al. “Prevalence of temporomandibular disorders in rheumatoid arthritis and associated risk factors: A nationwide study in Taiwan”. Journal of Oral Facial Pain Headache 31 (2017): e29-e36.
9. Sanders AE., et al. “Sleep apnea symptoms and risk of temporomandibular disorder: Oppera cohort”. Journal of Dental Research 92 (2013): 70S-77S.
10. Slade GD., et al. “Painful temporomandibular disorder: Decade of discovery from oppera studies”. Journal of Dental Research 95 (2016): 1084-1092.
11. E Sanders., et al. “Sleep Apnea Symptoms and Risk of Temporomandibular Disorder: OPPERA Cohort”. JDR Clinical Research Supplement1 (2013): 705-775.
12. Cunali P., et al. “Prevalence of Temporomandibular Disorders in Obstructive Sleep Apnea Patients Referred for Oral Appliance Therapy”. Journal of Orofacial Pain (2009).
13. Ju-Hui Wu., et al. “The Association between Temporomandibular Disorder and Sleep Apnea-A Nationwide Population-Based Cohort Study”. International Journal of Environmental Research Public Health 17 (2020): 6311.
14. Dubrovsky B., et al. “Polysomnographic investigation of sleep and respiratory parameters in women with temporomandibular pain disorders”. Journal of Clinical Sleep Medicine 2 (2014): 195-201.
15. Jeong-Hyun Kang and Hyun Jun Kim. “Potential role of obstructive sleep aponea on pain sensitization and jaw function in temporomandibular disorder patients”. Journal of Korean Medical Science 39 (2022): e307.
16. Yokoe T., et al. “Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure”. Circulation 8 (2003): 1129-1134.
17. Fang D., et al. “Interleukin-6-mediated functional upregulation of TRPV1 receptors in dorsal root ganglion neurons through the activation of JAK/PI3K signaling pathway: roles in the development of bone cancer pain in a rat model”. Pain 6 (2015): 1124-1144.
18. Kawasaki Y., et al. “Cytokine mechanisms of central sensitization: distinct and overlapping role of interleukin-1beta, interleukin-6, and tumor necrosis factor-alpha in regulating synaptic and neuronal activity in the superficial spinal cord”. Journal of Neuroscience 20 (2008): 5189-5194.
19. Ji RR., et al. “Neuroinflammation and central sensitization in chronic and widespread pain”. Anesthesiology2 (2018): 343-66.
20. de Feijter M., et al. “Polysomnography-estimated sleep and the negative feedback loop of the hypothalamic-pituitary-adrenal (HPA) axis”. Psychoneuroendocrinology 141 (2022): 105749.
21. Srijithesh PR., et al. “Positional therapy for obstructive sleep apnoea”. Cochrane Database of Systematic Reviews 5 (2019): CD010990.
22. Ashrafian H., et al. “Bariatric surgery or non-surgical weight loss for obstructive sleep apnoea? a systematic review and comparison of meta-analyses”. Obesity Surgery 7 (2015): 1239-1250.
23. Hudgel DW., et al. “American Thoracic Society Assembly on Sleep and Respiratory Neurobiology. The role of weight management in the treatment of adult obstructive sleep apnea: an official American Thoracic Society clinical practice guideline”. American Journal of Respiratory and Critical Care Medicine 6 (2018): e 70-e87.
24. Peppard PE and Young T. “Exercise and sleep-disordered breathing: an association independent of body habitus”. Sleep3 (2004): 480-484.
25. Kline CE., et al. “The effect of exercise training on obstructive sleep apnea and sleep quality: a randomized controlled trial”. Sleep12 (2011): 1631-1640.
26. Mendelson M., et al. “Effects of exercise training on sleep apnoea in patients with coronary artery disease: a randomised trial”. European Respiratory Journal 1 (2016): 142-150.
27. Iftikhar IH., et al. “Comparative efficacy of CPAP, MADs, exercise-training, and dietary weight loss for sleep apnea: a network meta-analysis”. Sleep Medicine 30 (2017): 7-14.
28. Qaseem A., et al. “Clinical Guidelines Committee of the American College of Physicians. Management of obstructive sleep apnea in adults: a clinical practice guideline from the American College of Physicians”. Annals of Internal Medicine 7 (2013): 471-483.
29. Ramar K., et al. “Clinical practice guideline for the treatment of obstructive sleep apnea and snoring with oral appliance therapy: an update for 2015”. Journal of Clinical Sleep Medicine 7 (2015): 773-827.

Citation

Citation: Ruchika Sood and Shweta Hinduja. “Inter-Relationship between OSA and TMD".Acta Scientific Dental Sciences 7.4 (2023): 26-29.

Copyright

Copyright: © 2023 Ruchika Sood and Shweta Hinduja. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.